DK1171440T3 - Substituerede 3-cyano-[1,7]-, [1,5]- og [1,8]-naphthyridininhibitorer af tyrosinkinaser - Google Patents

Substituerede 3-cyano-[1,7]-, [1,5]- og [1,8]-naphthyridininhibitorer af tyrosinkinaser

Info

Publication number
DK1171440T3
DK1171440T3 DK00926043T DK00926043T DK1171440T3 DK 1171440 T3 DK1171440 T3 DK 1171440T3 DK 00926043 T DK00926043 T DK 00926043T DK 00926043 T DK00926043 T DK 00926043T DK 1171440 T3 DK1171440 T3 DK 1171440T3
Authority
DK
Denmark
Prior art keywords
naphthyridine
cyano
inhibitors
substituted
tyrosine kinases
Prior art date
Application number
DK00926043T
Other languages
Danish (da)
English (en)
Inventor
Allan Wissner
Philip Ross Hamann
Ayako Yamashita
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1171440T3 publication Critical patent/DK1171440T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00926043T 1999-04-21 2000-04-18 Substituerede 3-cyano-[1,7]-, [1,5]- og [1,8]-naphthyridininhibitorer af tyrosinkinaser DK1171440T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29550799A 1999-04-21 1999-04-21
PCT/US2000/010250 WO2000066583A1 (fr) 1999-04-21 2000-04-18 3-cyano-[1.7], [1.5], et [1.8]-naphthyridine substitues, inhibiteurs des tyrosine kinases

Publications (1)

Publication Number Publication Date
DK1171440T3 true DK1171440T3 (da) 2004-08-02

Family

ID=23138006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00926043T DK1171440T3 (da) 1999-04-21 2000-04-18 Substituerede 3-cyano-[1,7]-, [1,5]- og [1,8]-naphthyridininhibitorer af tyrosinkinaser

Country Status (23)

Country Link
EP (1) EP1171440B1 (fr)
JP (1) JP2002543198A (fr)
KR (1) KR20020002433A (fr)
CN (1) CN100408576C (fr)
AR (1) AR029880A1 (fr)
AT (1) ATE264328T1 (fr)
AU (1) AU776962B2 (fr)
BR (1) BR0009870A (fr)
CA (1) CA2365212A1 (fr)
CZ (1) CZ20013660A3 (fr)
DE (1) DE60009888T2 (fr)
DK (1) DK1171440T3 (fr)
ES (1) ES2216884T3 (fr)
HK (1) HK1040077B (fr)
HU (1) HUP0200816A3 (fr)
IL (1) IL145870A0 (fr)
NO (1) NO20015062D0 (fr)
NZ (1) NZ514576A (fr)
PL (1) PL350920A1 (fr)
PT (1) PT1171440E (fr)
RU (1) RU2001131356A (fr)
WO (1) WO2000066583A1 (fr)
ZA (1) ZA200108015B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2003002287A1 (es) * 2002-11-25 2005-01-14 Wyeth Corp COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
US7276519B2 (en) 2002-11-25 2007-10-02 Wyeth Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
BRPI0611521A2 (pt) * 2005-05-18 2010-09-14 Wyeth Corp inibidores de 4,6-diamino-[1,7]naftiridina-3-carbonitrila de quìnase tpl2 e métodos de fabricação e uso dos mesmos
CA2635813C (fr) 2006-01-31 2014-01-07 Array Biopharma, Inc. Derives d'uree en tant qu'inhibiteurs de kinase et leurs procedes d'utillisation
ES2301380B1 (es) * 2006-08-09 2009-06-08 Laboratorios Almirall S.A. Nuevos derivados de 1,7-naftiridina.
ES2320955B1 (es) 2007-03-02 2010-03-16 Laboratorios Almirall S.A. Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
ES2329639B1 (es) * 2007-04-26 2010-09-23 Laboratorios Almirall S.A. Nuevos derivados de 4,8-difenilpoliazanaftaleno.
EP2108641A1 (fr) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. Nouveaux dérivés substitués de spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one et leur utilisation comme ihibiteurs de p38 mitogen-activated kinase
EP2113503A1 (fr) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. Nouveaux dérivés d'indolin-2-one substitués et leur utilisation comme inhibiteurs de p38 mitogen-activated kinase
TW201111376A (en) * 2009-06-25 2011-04-01 Amgen Inc Heterocyclic compounds and their uses
EP2332939A1 (fr) 2009-11-26 2011-06-15 Æterna Zentaris GmbH Nouveaux dérivés de naphtyridine et l'utilisation associée en tant qu'inhibiteurs de kinase
WO2012060847A1 (fr) 2010-11-07 2012-05-10 Targegen, Inc. Compositions et procédés de traitement de la myélofibrose
CN102675311A (zh) * 2011-06-14 2012-09-19 苏春华 一种氟代丙烯酰胺的衍生物
RU2014133390A (ru) 2012-01-30 2016-03-20 Ф. Хоффманн-Ля Рош Аг Производные изохинолина и нафтиридина
UY35772A (es) 2013-10-14 2015-05-29 Bayer Cropscience Ag Nuevos compuestos plaguicidas
CA3228632A1 (fr) 2015-12-24 2017-06-29 Kyowa Kirin Co., Ltd. Compose amide .alpha.,.beta.-insature
CN107556309B (zh) * 2017-09-11 2020-12-01 浙江永宁药业股份有限公司 多取代四氢萘啶类化合物的药物用途及其制备方法
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
ATE300521T1 (de) * 1996-09-25 2005-08-15 Astrazeneca Ab Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
TW436485B (en) * 1997-08-01 2001-05-28 American Cyanamid Co Substituted quinazoline derivatives

Also Published As

Publication number Publication date
CA2365212A1 (fr) 2000-11-09
EP1171440A1 (fr) 2002-01-16
WO2000066583A1 (fr) 2000-11-09
AU4463900A (en) 2000-11-17
AR029880A1 (es) 2003-07-23
DE60009888D1 (de) 2004-05-19
IL145870A0 (en) 2002-07-25
JP2002543198A (ja) 2002-12-17
AU776962B2 (en) 2004-09-30
HK1040077A1 (en) 2002-05-24
NZ514576A (en) 2004-02-27
HUP0200816A3 (en) 2003-06-30
BR0009870A (pt) 2002-01-08
CZ20013660A3 (cs) 2002-01-16
PT1171440E (pt) 2004-07-30
ATE264328T1 (de) 2004-04-15
NO20015062L (no) 2001-10-18
NO20015062D0 (no) 2001-10-18
HK1040077B (zh) 2004-09-10
CN100408576C (zh) 2008-08-06
CN1347416A (zh) 2002-05-01
RU2001131356A (ru) 2003-06-27
KR20020002433A (ko) 2002-01-09
HUP0200816A2 (en) 2002-08-28
PL350920A1 (en) 2003-02-10
DE60009888T2 (de) 2005-04-21
ZA200108015B (en) 2003-03-26
ES2216884T3 (es) 2004-11-01
EP1171440B1 (fr) 2004-04-14

Similar Documents

Publication Publication Date Title
HUS1700048I1 (hu) Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai
DK1171440T3 (da) Substituerede 3-cyano-[1,7]-, [1,5]- og [1,8]-naphthyridininhibitorer af tyrosinkinaser
DZ3223A1 (fr) Inhibiteurs de tyrosine kinases
HK1244797A1 (zh) 環蛋白酪氨酸激酶抑制劑
DK1000039T3 (da) Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
DK1117659T3 (da) Substituerede 3-cyanoquinoliner som hæmmere af proteintyrosinkinaser
HK1053124A1 (en) Substituted quinazoline derivatives and their use as inhibitors
DK1183033T3 (da) Pyrrolotriazininhibitorer af kinaser
ZA986729B (en) Irreversible inhibitors of tyrosine kinases
PT1177195E (pt) 1-amino-triazolo¬4,3-a|quinazolina-5-onas e/ou -5-tionas inibidoras de fosfodiesterases iv
AU3885900A (en) Inhibitors of the egf-receptor tyrosine kinase and their use
AU2876000A (en) Tyrosine kinase inhibitors and methods of using the same